Gilead and Verily Announce Scientific Collaboration to Identify and Understand Immunological and Molecular Drivers of Inflammatory Diseases

Go back to Gilead and Verily Announce Scientific Collaboration to Identify and Understand Immunological and Molecular Drivers of Inflammatory Diseases
Gilead Sciences (NASDAQ: GILD) Delayed: 125.05 +0.18 (0.14%)
Previous Close $124.87    52 Week High $108.63 
Open $126.63    52 Week Low $71.39 
Day High $126.63    P/E 69.09 
Day Low $124.44    EPS $1.81 
Volume 8,462,588